Angiotech Pharmaceuticals announces FDA approval of next-generation TAXUS(R) Liberte(R) Atom(TM) Stent system
... coronary vessels. It was approved for use in
vessels as small as 2.25 mm in diameter and joins the ... percutaneous coronary interventions have small
vessels ((less than)2.5 mm). Until recently, many ... treatment choice for patients with small
vessels who will now have the additional option of the ...
FDA Approves Boston Scientific's Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
... coronary vessels. It was approved for use in
vessels as small as 2.25 mm in diameter and joins the ... percutaneous coronary interventions have small
vessels (<2.5 mm). Until recently, many physicians ... treatment choice for patients with small
vessels who will now have the additional option of the ...
Old and new therapies combine to tackle atherosclerosis
... plus a statin could stop the growth of tiny blood
vessels that feed arterial plaques. Their results suggest that the dual treatment also prevents the
vessels from restarting their growth, which could shrink ... a substance that made them stick in growing blood
vessels and with fumagillin, a potent compound that stops ...
ThromboGenics N.V. - Business Update
... that blocks the formation of
the new blood
vessels that are needed by solid tumours to support ... to competing
agents, TB-403 only blocks blood
vessels in tumour tissue and not in
healthy tissue. This ... RESISTANT TUMORS WITHOUT AFFECTING HEALTHY
vessels -
Christian Fischer, Bart Jonckx, Massimiliano ...
European Regulatory Agency Supports OPAXIO(TM) Brand Name for Cell Therapeutics' Lung Cancer Drug
... chemotherapy and its associated toxicities. Blood
vessels in tumor
tissue, unlike blood
vessels in normal tissue, are porous to molecules ... distributed to tumors due to their leaky blood
vessels and
trapped in the tumor bed allowing ...
Publication in Clinical Cancer Research Confirms Ability of Peregrine's Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
... specificity of bavituximab to target
tumor blood
vessels with little or no localization to normal ... localized to the tumor blood
vessels with great specificity. In
these subjects, 22 ... evidence
that bavituximab targets tumor blood
vessels with excellent specificity,"
said Steven W. King, ...
Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule
... chemotherapy and its associated
toxicities. Blood
vessels in tumor tissue, unlike blood
vessels in normal
tissue, are porous to molecules like ... distributed to tumors due
to their leaky blood
vessels and trapped in the tumor bed ...
Presentation of Phase IIa Results for Cytos Biotechnology's Hypertension Vaccine at the American Heart Association Scientific Sessions 2007
... of blood pressure. Angiotensin II causes
blood
vessels to narrow, resulting in increased blood pressure. ... receptors and subsequent narrowing of blood
vessels should be
decreased. The RAS has already been ... of the RAS inducing vasoconstriction of
blood
vessels and other effects to raise blood pressure. ...
Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
... chemotherapy and its associated toxicities. Blood
vessels in tumor
tissue, unlike blood
vessels in normal tissue, are porous to molecules ... distributed to tumors due to their leaky blood
vessels and
trapped in the tumor bed allowing ...
Cardica Receives European CE Mark for C-Port Flex A System for Use in Coronary Artery Bypass Surgery
... the
automated anastomosis, or attachment of blood
vessels and grafts, during
less invasive coronary artery ... reliable
and reproducible connections of blood
vessels during CABG surgery. The
C-Port Flex A system has ... is effective
in creating compliant anastomoses in
vessels as small as one millimeter in
internal diameter; ...
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
... system involved in regulating tumor angiogenesis, the growth of blood
vessels in tumors. He discovered that inhibiting a key player in the signaling ... growth factor receptor or VEGFR) suppresses the generation of blood
vessels in tumors and slows down cancer cell growth. Years later, a small molecule ...
Calvert Research Licenses Novel Technology to Treat Age Related Macular Degeneration from Tulane University
... (atrophic) and wet (exudative) form. Wet AMD occurs when abnormal blood
vessels behind the retina begin to grow under the macula, often leaking blood and ... drug candidate designed to specifically target and kill abnormal blood
vessels found in wet AMD patients.
The lead compound from this technology ...
AngioGenex Presents Data on its Id Targeted Anti-Angiogenesis Inhibitors at Two Scientific Conferences
... either the Id genes or proteins to prevent the formation of new blood
vessels into tumors (angiogenesis). The Company's technology is based on the ... that activation of the Id genes is required for the formation of new blood
vessels into tumors, allowing tumors to grow and metastasize. Dr. Benezra ...
OmegaGenesis Announces Angiogenesis Application Collaboration
... spread of cancer and malignancies. In cancer and malignancies, new blood
vessels feed the cancer cells with oxygen and nutrients, allowing these cells to ... the current limitation of therapy to create new functional blood
vessels in ischemic diseases, this finding has significant potential for clinical ...
Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug
... blood cells and normally spreads through the lymphatic system, a system
of
vessels that drains fluid from the body. NHL can be broadly classified into
two ... blood cells and normally spreads through the lymphatic system, a system
of
vessels that drains fluid from the body. NHL can be broadly classified into
two ...
AngioGenex Reviews 2008 Achievements and Sets Goals for 2009
... either the Id genes or proteins to prevent the formation of new blood
vessels into tumors (angiogenesis). The Company's technology is based on the ... that activation of the Id genes is required for the formation of new blood
vessels into tumors, allowing tumors to grow and metastasize. Dr. Benezra ...
CorMatrix Announces Pre-Clinical Data Suggesting Next Generation ECM Technology(TM) Can Improve Cardiac Function
... enhanced, evidenced by
increased density value of a-SMA-positive
vessels (70+/-10 vs. 20+/-4/HPF)
and vWF-positive
vessels (95+/-14 vs. 34+/-8/HPF). At 42 days post
reperfusion, echocardiography ...
FDA Approves Orphan Drug Status for Revolutionary Cancer Drug for Children
... formulation which allows the matter to
migrate through the body's own
vessels directly to the tumor cells. When
the tumor cells uptake the matter, they ... cells -- The product is so small that it migrates right through blood
vessels and cell walls -- This technology be applied to other diseases in the ...
33rd ESMO Congress in Stockholm, 12-16 September 2008
... 2008, 10:00 CEST)
A new form of chemotherapy that destroys new blood
vessels that grow
around tumours has produced excellent results in a phase II ... drug that combats ovarian cancer by inhibiting the
formation of new blood
vessels has shown promise in a phase II trial,
according to Prof. Michael ...
BugLab Launches Noninvasive Biomass Monitor for Continuous, On-Line Measurements
... to the outside of a variety of
different fermentor types, from small glass
vessels to large stainless
steel
vessels with glass viewing ports. Since no immersion port is
required, it avoids ...
AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs
... either the Id
genes or proteins to prevent the formation of new blood
vessels into tumors
(angiogenesis). The Company's technology is based on the ... that activation of the Id
genes is required for the formation of new blood
vessels into tumors,
allowing tumors to grow and metastasize. Dr. Benezra ...
Peregrine Pharmaceuticals Presents Promising Phase I Data at ASCO and Provides Clinical Update on Its Phase II Bavituximab Breast Cancer Study
... helps mobilize the body's own immune system to attack tumors and the
blood
vessels supporting tumor growth and spread," said Dr. Raghunadharao
Digumarti, ... but which
becomes exposed on the outside of the cells that line the blood
vessels of
tumors, creating a specific target for anti-cancer treatments. By ...
ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
... About Stroke
Stroke is a cardiovascular disease affecting the blood
vessels of the
brain. Stroke is caused by a blockage of the blood
vessels of the brain,
depriving the brain of oxygen, and can result in severe ...
Angiotech announces commercial launch of Cook Medical's Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand
... Artery Disease (PAD)
Peripheral Artery Disease (PAD) affects blood
vessels that lead from
the heart to other areas of the body, such as the legs, feet and kidneys.
When the blood
vessels become blocked due to the build-up of fatty
deposits, blood circulation is ...
Vical Licensee AnGes MG Files NDA in Japan for Collategene Angiogenesis Product
... factor (HGF), a human protein that causes growth of blood
vessels in
areas of restricted blood flow.
"The Japanese NDA filing positions ... which occurs by decreased blood flow caused by
narrowing of blood
vessels as a result of arteriosclerosis, and ischemic
heart disease.
This is a ...
Escalon(R) Announces FDA 510(K) Clearance for VascuView(TM) Visual Ultrasound System For Assisted Vascular Access
... -- Large image display providing easy visualization of targeted
vessels and surrounding anatomy
-- Touchscreen display with intuitive and ... vascular access assemblies,
which are used to locate desired
vessels for access. These patented devices
utilize a miniature Doppler ultrasound ...
Cardica and Intuitive Surgical to Host Educational Symposium on 'Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair'
... to enable automated, reliable and
reproducible connections of blood
vessels during CABG surgery. Unlike most
hand-sewn anastomoses, Cardica's C-Port ... than rigid, shaft and is
designed to create compliant anastomoses in
vessels as small as one
millimeter in internal diameter. Importantly, the flexible ...
Researchers use magnetism to target cells to animal arteries
... heart disease commonly receive metal stents in partially blocked blood
vessels to improve blood flow, both by widening the
vessels and delivering drugs. However, many stents fail over time as smooth muscle ...
JCI table of contents: Dec. 3, 2007
... a patients chances of survival are very poor. The functionality of small
vessels feeding the transplanted organ is likely to play a key role in preventing ... to organ tissues, researchers examined the functionality of mouse blood
vessels following tracheal transplants where surgical revascularization was not ...
ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis Inhibitors in Cell
... are due to PIGF inhibitors acting by
blocking the formation of new blood
vessels only in the cancer tissue. ThromboGenics and BioInvent have made the ... in diseased conditions, without, importantly, affecting normal
blood
vessels in healthy tissues. These findings pave the way for the development of a ...
On the road to a new cancer therapy -- starving the tumor
... growth factors. These growth factors stimulate the formation of blood
vessels that feed the tumor cells. In this way, even the innermost part of the ... to develop new therapies for cancer. Indeed, when the formation of blood
vessels that feed tumor cells is blocked, the tumor starves due to the lack of ...
Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
... (TTP), marked by the formation of platelet-rich blood clots in
blood
vessels throughout the body. Recombinant ADAMTS13 is being developed
for the ... that is caused by the formation of
platelet- rich thrombi in blood
vessels throughout the body. Hereditary
TTP, also known as Upshaw Schulman ...
ChemoCentryx Demonstrates Recently Discovered Chemokine Receptor CXCR7 is Essential in Tumor Growth
... by both the malignant tumor cells and by the tumor-associated
blood
vessels in the tumor mass, but not found on healthy cells or normal
vasculature ... strongly suggesting that
CXCR7 is central to the formation of new blood
vessels during development
(a process known to resemble aspects of new blood ...
Study Published in Clinical Cancer Research Confirms Potential Of Peregrine's Bavituximab Combined With Radiation In Lung Cancer
... may have contributed to the finding that the density of tumor
blood
vessels was reduced by more than 90% and tumor growth was reduced by
80% in ... is believed to help mobilize the body's immune system to
destroy the blood
vessels needed for tumor growth and spread. In a Phase lb
trial in advanced cancer ...
ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007
... is a humanized monoclonal antibody that blocks the
formation of new blood
vessels in solid tumors. By blocking the formation
of new blood
vessels (anti-angiogenesis), TB-403 has the potential to
reduce the growth and ...
Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
... stent system, a next-generation paclitaxel-eluting stent specifically designed for treating small coronary vessels. It was approved for use in
vessels as small as 2.25 mm in diameter and joins the TAXUS Express Atom(TM) stent as the only drug-eluting stents ("DES") approved for small vessel use in ...
PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2
... of VEGF.
(Logo: http://www.newscom.com/cgi-bin/prnh/20010919/PTCLOGO )
VEGF plays a critical role in the formation of new blood
vessels or angiogenesis and its suppression has been shown to decrease tumor size and improve hearing in some patients with NF2. PTC299 selectively blocks ...
Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration
... suggest heart problems, such as chest pain or fainting.
Vyvanse should not be taken if you or your child has advanced disease of the blood
vessels (arteriosclerosis); symptomatic heart disease; moderate to severe high blood pressure; overactive thyroid gland (hyperthyroidism); known allergy or ...
Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost
... cost of failure are both great.
"Unlike a long range missile, the millions of shipping containers that are used to transport goods in ocean-going
vessels provide terrorists with a way to hide a nuclear device destined for U.S. shores," they write. "Further, by using a container, terrorists can ...
Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment
... that suggest heart problems, such as chest pain or fainting.
Vyvanse should not be taken if you or your child has advanced disease of the blood
vessels (arteriosclerosis); symptomatic heart disease; moderate to severe high blood pressure; overactive thyroid gland (hyperthyroidism); known allergy or ...